Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

P

PVLA

Palvella Therapeutics Inc

151.97

Jul 15 • 03:59PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS NUVL BMRN INCY AXSM NBIX

| Held by: XBI VTI IWM IWO VXF VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.18B
Enterprise Value	1.94B
Income	-49.30M
Sales	0.00M
Book/sh	16.23
Cash/sh	18.26
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.36
P/C	8.32
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	28.88
Current Ratio	28.88
Debt/Eq	0.09
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-6.43
EPS next Q	-1.16
EPS this Y	-48.88%
EPS next Y	-16.45%
EPS next 5Y	12.81%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	66.94%
Sales Y/Y TTM	-
EPS Q/Q	-62.12%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	-28.34% -

Insider Own	29.40%
Insider Trans	-0.45%
Inst Own	82.77%
Inst Trans	33.23%
ROA	-28.73%
ROE	-34.25%
ROIC	-19.52%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	10.32%
SMA50	22.44%
SMA200	44.79%
Trades

Shs Outstand	14.31M
Shs Float	10.13M
Short Float	23.36%
Short Ratio	9.07
Short Interest	2.37M
52W High	161.38 -5.83%
52W Low	26.98 463.27%
Volatility	6.07% 6.96%
ATR (14)	9.10
RSI (14)	62.85
Beta	-0.18
Rel Volume	0.00
Avg Volume	260.94K
Volume	0

Perf Week	4.67%
Perf Month	39.67%
Perf Quarter	17.32%
Perf Half Y	51.23%
Perf YTD	45.19%
Perf Year	448.63%
Perf 3Y	874.17%
Perf 5Y	-46.03%
Perf 10Y	11.09%
Recom	1.00
Target Price	229.00
Prev Close	151.97
Price	151.97
Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)